Femoral atherosclerosis in heterozygous familial hypercholesterolemia influence of the genetic defect

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 28, Issue 3, 2008, Pages 580-586

  Junyent, Mireia ^a   Gilabert, Rosa ^b   Zambón, Daniel ^a   Pocoví, Miguel ^c   Mallén, Miguel ^c   Cofán, Montserrat ^a   Núñez, Isabel ^b   Civeira, Fernando ^d   Tejedor, Diego ^e   Ros, Emilio ^a,f  

^a Centre de Diagnòstic per l'Imatge   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF ZARAGOZA   (Spain)

^d HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^e Progenika Biopharma SA   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

Author keywords

Apolipoprotein B mutations; Atheroma plaque; Familial hypercholesterolemia; Femoral atherosclerosis; Intima media thickness; Low density lipoprotein receptor mutations

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; SIMVASTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALLELE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CLINICAL FEATURE; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FEMORAL ARTERY; GENE MUTATION; GENE REARRANGEMENT; GENETIC DISORDER; GENOTYPE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 2; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; ONSET AGE; PRIORITY JOURNAL; PROTEIN DEFECT; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; XANTHOMA; AGE DISTRIBUTION; AGED; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; DOPPLER FLOWMETRY; ECHOGRAPHY; FOLLOW UP; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE DETECTION; INCIDENCE; INTIMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROBABILITY; REFERENCE VALUE; SEX RATIO;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE DETECTION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROBABILITY; REFERENCE VALUES; SEX DISTRIBUTION; TUNICA INTIMA; ULTRASONOGRAPHY, DOPPLER;

EID: 40749125735     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.107.153841     Document Type: Article

References (35)

1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Baudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill;2001: 2863-2913.
2. Soria LF, Ludwig EH, Clarke HRG, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A. 1989; 96:587-591.
3. Abifadel M, Varret M, Rabes JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derre A, Villeger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C. Mutations in PCSK9 cause autosomal dominant hypercholes-terolemia. Nat Genet. 2003;34:154-156.
4. Aalst-Cohen E, Jansen AC, Tanck M, Defesche JC, Trip M, Lansberg P, Stalenhoef A, Kastelein JJ. Diagnosing familial hypercholester-olaemia: the relevance of genetic testing. Eur Heart J. 2006;27: 2240-2246.
5. Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol. 2004;160:407-420.
6. Austin MA, Hutter CM, Zimmern RL, Humphries SE. Familial hypercholesterolemia and coronary heart disease: a HuGE association. Am J Epidemiol. 2004;160:421-429.
7. Humphries SE, Whittall RA, Hubbart CS, Maplebeck S, Cooper JA, Soutar AK, Naoumova R, Thompson GR, Seed M, Durrington PN, Miller JP, Betteridge DJB, Neil HAW for the Simon Broome Familial Hyperlipidaemia Register Group and Scientific Steering Committee. Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk. J Med Genet. 2006; 43:943-949.
8. Fouchier SW, Kastelein JJ, Defesche JC. Update of the molecular basis of familial hypercholesterolemia in The Netherlands. Hum Mutat. 2005;26: 550-556.
9. Cheng K-S, Mikhailidis D, Hamilton G, Seifalian A. A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc Res. 2002;54:528-538.
10. Bots ML, Baldassarre D, Simon A, de Groot E, O'Leary DH, Riley W, Kastelein JJ, Grobbee DE. Carotid intima-media thickness and coronary atherosclerosis: weak or strong relations? Eur Heart J. 2007; 28:398-406.
11. Kekäläinen P, Sarlund H, Farin P, Kaikanen E, Yang X, Laakso M. Femoral atherosclerosis in middle-aged subjects: association with cardiovascular risk factors and insulin resistance. Am J Epidemiol. 1996;144: 742-748.
12. Smilde TJ, van den Berkmortel F, Boers G, Wollersheim H, De Boo T, Van Langen H, Stalenhoef A. Carotid and femoral artery wall thickness and stiffness in patients at risk for cardiovascular disease, with special emphasis on hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 1998;18:1958-1963.
13. Paul TK, Srinivasan SR, Chen W, Li S, Bond G, Tang R, Berenson G. Impact of multiple cardiovascular risk factors on femoral artery intima-media thickness in asymptomatic young adults (The Bogalusa Heart Study). Am J Cardiol. 2005;95:469-473.
14. Held C, Hjelmdahl P, Eriksson SV, Björkander I, Forslund L, Rehnqvist N. Prognostic implications of intima-media thickness and plaques in the carotid and femoral arteries in patients with stable angina pectoris. Eur Heart J. 2001;22:62-72.
15. Wittekoek M, De Groot E, Prins M, Trip M, Büller H, Kastelein JJ. Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease. Atherosclerosis. 1999;146: 271-279.
16. Nolting PR, de Groot E, Zwinderman AH, Buirma RJ, Trip MD, Kastelein JJ. Regression of carotid and femoral artery intima-media thickness in familial hypercholesterolemia: treatment with simvastatin. Arch Intern Med. 2003;163:1837-1841.
17. Schmidt C, Fagerberg B, Hulthe J. Non-stenotic echolucent ultrasound-assessed femoral artery plaques are predictive for future cardiovascular events in middle-aged men. Atherosclerosis. 2005;181:125-130.
18. Wendelhag I, Wiklund O, Wikstrand J. Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence. Arterioscler Thromb. 1993;13:1404-1411.
19. de Groot E, Hovingh K, Wiegman A, Duriez P, Smit A, Fruchart J-C, Kastelein JJ Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation. 2004;109(suppl III):III-33-III-38.
20. Descamps OS, Gilbeau J-P, Leysen X, Van Leuven F, Heller FR. Impact of genetic defects on atherosclerosis in patients suspected of familial hypercholesterolaemia. Eur J Clin Invest. 2001;31:958-965.
21. Pocovi M, Civeira F, Alonso R, Mata P. Familial hypercholesterolemia in Spain: case-finding program, clinical and genetic aspects. Semin Vasc Med. 2004;4:67-74.
22. Myant NB. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemia. Atherosclerosis. 1993;104:1-18.
23. Real J, Chaves F, Ejarque I, García-Garcia A, Valldecabres C, Ascaso J, Armengod M, Carmena R. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population. Eur J Hum Genet. 2003;11:959-965.
24. Bertolini S, Cantafora A, Averna M, Cortese C, Motti C, Martini S, Pes G, Postiglione A, Stefanutti C, Blotta I, Pisciotta L, Rolleri M, Langheim S, Ghisellini M, Rabbone I, Calandra S. Clinical expression of familial hypercholesterolemia in clusters of mutations of the LDL receptor gene that cause a receptor-defective or receptor-negative phenotype. Arterioscler Thromb Vasc Biol. 2000;20:e41-e52.
25. Umans-Eckenhausen MA, Sijbrands EJ, Kastelein JJ, Defesche JC. Lowdensity lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population. Circulation. 2002;106: 3031-3036.
26. Tonstad S, Joakimsen O, Stensland Bugge E, Ose L, Bonaa KH, Leren TP. Carotid intima-media thickness and plaque in patients with familial hypercholesterolemia mutations and control subjects. Eur J Clin Invest. 1998;28:971-979.
27. Koeijvoets KC, Rodenburg J, Hutten BA, Wiegman A, Kastelein JJ, Sijbrands EJ. Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia. Substudy of an intima-media thickness trial. Circulation. 2005;112:3168-3173.
28. Ueland T, Vissers MN, Wiegman A, Rodenburg J, Hutten B, Gullestad L, Ose L, Rifai N, Ridker PM, Kastelein JJ, Aukrust P, Semb AG. Increased inflammatory markers in children with familial hypercholesterolaemia. Eur J Clin Invest. 2006;36:147-152.
29. Holven KB, Myhre AM, Aukrust P, Hagve TA, Ose L, Nenseter MS. Patients with familial hypercholesterolaemia show enhanced spontaneous chemokine release from peripheral blood mononuclear cells ex vivo. Dependency of xanthomas/xanthelasms, smoking and gender. Eur Heart J. 2003;24:1756-1762.
30. Artieda M, Cenarro A, Junquera C, Lasierra P, Martínez-Lorenzo MJ, Pocoví M, Civeira F. Tendon xanthomas in familial hypercholesterolemia are associated with a differential inflammatory response of macrophages to oxidized LDL. FEBS Lett. 2005;579:4503-4512.
31. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease. An update. J Am Coll Cardiol. 2004;43:1731-1737.
32. Tybjærg-Hansen A, Jensen HK, Benn M, Steffensen R, Jensen G, Nordestgaard BG. Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations. Arterioscler Thromb Vasc Biol. 2005;25:211-215.
33. Damgaard D, Jensen JM, Larsen ML, Soerensen VR, Jensen HK, Gregersen N, Jensen LG, Faergeman O. No genetic linkage or molecular evidence for involvement of the PCSK9, ARH or CYP7A1 genes in the familial hypercholesterolemia phenotype in a sample of Danish families without pathogenic mutations in the LDL receptor and apoB genes. Atherosclerosis. 2004;177:415-422.
34. Sun XM, Patel DD, Bhatnagar D, Knight BL, Soutar AK. Characterization of a splice-site mutation in the gene for the LDL receptor associated with an unpredictably severe clinical phenotype in English patients with heterozygous FH. Arterioscler Thromb Vasc Biol. 1995;15:219-227.
35. Damgaard D, Larsen ML, Nissen PH, Jensen JM, Jensen HK, Soerensen VR, Jensen LG, Faergeman O. The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population. Atherosclerosis. 2005;180:155-160.